Battista M, Hoffmann B, Bachelot Y, Zimmermann L, Teuber L, Jost A
mSphere. 2023; 8(4):e0014223.
PMID: 37358300
PMC: 10449520.
DOI: 10.1128/msphere.00142-23.
Gil E, Noursadeghi M, Brown J
Front Cell Infect Microbiol. 2022; 12:929483.
PMID: 35967850
PMC: 9366601.
DOI: 10.3389/fcimb.2022.929483.
Cole J, Angyal A, Emes R, Mitchell T, Dickman M, Dockrell D
Front Immunol. 2021; 12:573266.
PMID: 34046027
PMC: 8145618.
DOI: 10.3389/fimmu.2021.573266.
Kilian M, Tettelin H
mBio. 2019; 10(5).
PMID: 31481387
PMC: 6722419.
DOI: 10.1128/mBio.01985-19.
Haleem K, Ali Y, Yesilkaya H, Kohler T, Hammerschmidt S, Andrew P
Infect Immun. 2018; 87(1).
PMID: 30323030
PMC: 6300637.
DOI: 10.1128/IAI.00742-18.
Mucosal Infections and Invasive Potential of Nonencapsulated Are Enhanced by Oligopeptide Binding Proteins AliC and AliD.
Bradshaw J, Pipkins H, Keller L, Pendarvis J, McDaniel L
mBio. 2018; 9(1).
PMID: 29339428
PMC: 5770551.
DOI: 10.1128/mBio.02097-17.
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials.
Maestro B, Sanz J
Antibiotics (Basel). 2016; 5(2).
PMID: 27314398
PMC: 4929436.
DOI: 10.3390/antibiotics5020021.
Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
Keller L, Bradshaw J, Pipkins H, McDaniel L
Front Cell Infect Microbiol. 2016; 6:55.
PMID: 27242973
PMC: 4870244.
DOI: 10.3389/fcimb.2016.00055.
Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
Greene C, Marks L, Hu J, Reddinger R, Mandell L, Roche-Hakansson H
Infect Immun. 2016; 84(6):1693-1703.
PMID: 27001538
PMC: 4907141.
DOI: 10.1128/IAI.01478-15.
Pneumococcal Capsules and Their Types: Past, Present, and Future.
Geno K, Gilbert G, Song J, Skovsted I, Klugman K, Jones C
Clin Microbiol Rev. 2015; 28(3):871-99.
PMID: 26085553
PMC: 4475641.
DOI: 10.1128/CMR.00024-15.
Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.
Kaur R, Surendran N, Ochs M, E Pichichero M
Infect Immun. 2014; 82(12):5069-75.
PMID: 25245804
PMC: 4249272.
DOI: 10.1128/IAI.02124-14.
Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.
Verhoeven D, Perry S, E Pichichero M
Clin Vaccine Immunol. 2014; 21(8):1037-45.
PMID: 24850621
PMC: 4135924.
DOI: 10.1128/CVI.00052-14.
Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence.
Agarwal V, Sroka M, Fulde M, Bergmann S, Riesbeck K, Blom A
J Biol Chem. 2014; 289(22):15833-44.
PMID: 24739385
PMC: 4140937.
DOI: 10.1074/jbc.M113.530212.
Human L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae.
Ali Y, Kenawy H, Muhammad A, Sim R, Andrew P, Schwaeble W
PLoS One. 2013; 8(12):e82583.
PMID: 24349316
PMC: 3861440.
DOI: 10.1371/journal.pone.0082583.
Contribution of different pneumococcal virulence factors to experimental meningitis in mice.
Ricci S, Gerlini A, Pammolli A, Chiavolini D, Braione V, Tripodi S
BMC Infect Dis. 2013; 13:444.
PMID: 24059458
PMC: 3848944.
DOI: 10.1186/1471-2334-13-444.
Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A.
Daniels C, Kim K, Burton R, Mirza S, Walker M, King J
Clin Vaccine Immunol. 2013; 20(10):1549-58.
PMID: 23925886
PMC: 3807198.
DOI: 10.1128/CVI.00371-13.
Role of pore-forming toxins in bacterial infectious diseases.
Los F, Randis T, Aroian R, Ratner A
Microbiol Mol Biol Rev. 2013; 77(2):173-207.
PMID: 23699254
PMC: 3668673.
DOI: 10.1128/MMBR.00052-12.
Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.
Goulart C, da Silva T, Rodriguez D, Politano W, Leite L, Darrieux M
PLoS One. 2013; 8(3):e59605.
PMID: 23533636
PMC: 3606166.
DOI: 10.1371/journal.pone.0059605.
PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization.
Keller L, Jones C, Thornton J, Sanders M, Swiatlo E, Nahm M
Infect Immun. 2012; 81(1):173-81.
PMID: 23115034
PMC: 3536125.
DOI: 10.1128/IAI.00755-12.
The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.
Ren B, Li J, Genschmer K, Hollingshead S, Briles D
Clin Vaccine Immunol. 2012; 19(10):1574-82.
PMID: 22855389
PMC: 3485889.
DOI: 10.1128/CVI.00393-12.